2m 2m 2m 2m 2m 2m 2m
NUVATION BIO-A (NUVB)
NYSE
$4.29+$0.09 (+2.17%)
Price as of Nov 11, 2026 7:35 PM EST- $1.5BMarket Cap
- -15.66%1-Year Change
- BiotechnologyIndustry
NUVATION BIO-A (NUVB)
$4.29+$0.09 (+2.17%)
NUVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.20 | ||
Change | -$0.15 (-3.45%) | ||
Open | $4.23 | ||
High | $4.36 | ||
Low | $4.11 | ||
Previous Close | $4.35 | ||
Volume | 3,479,164 | ||
30-Day Average Volume | 5,172,270 | ||
1-Week Change | -10.45% | ||
1-Month Change | -16.00% | ||
1-Year Change | -15.66% | ||
3-Year Change | 225.58% | ||
5-Year Change | -51.89% | ||
Fundamentals | |||
Shares Outstanding | 352.0M | ||
Total Assets | $778.4M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $27.5M | ||
Net Income | -$41.9M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$41.0M | ||
EBITDA | -$40.4M | ||
Net Working Capital | $636.1M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | 59 | ||
P/B | 6 | ||
P/E | -35 | ||
PEG | -1 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue